Anthony C Hooper - Net Worth and Insider Trading
Anthony C Hooper Net Worth
The estimated net worth of Anthony C Hooper is at least $12 Million dollars as of 2024-09-20. Anthony C Hooper is the SVP ComOps Pres USJap Int of Bristol-Myers Squibb Co and owns about 208,419 shares of Bristol-Myers Squibb Co (BMY) stock worth over $10 Million. Anthony C Hooper is also the Director of MannKind Corp and owns about 338,394 shares of MannKind Corp (MNKD) stock worth over $2 Million. Details can be seen in Anthony C Hooper's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony C Hooper has not made any transactions after 2022-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anthony C Hooper
Anthony C Hooper Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony C Hooper owns 4 companies in total, including BeiGene Ltd (BGNE) , MannKind Corp (MNKD) , and Amgen Inc (AMGN) among others .
Click here to see the complete history of Anthony C Hooper’s form 4 insider trades.
Insider Ownership Summary of Anthony C Hooper
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BGNE | BeiGene Ltd | 2020-01-02 | director |
| MNKD | MannKind Corp | 2022-02-28 | director |
| AMGN | Amgen Inc | 2011-10-27 | EVP & Global Commercial Ops. |
 | | 2011-05-13 | President US Pharmaceuticals |
Anthony C Hooper Latest Holdings Summary
Anthony C Hooper currently owns a total of 2 stocks. Among these stocks, Anthony C Hooper owns 208,419 shares of Bristol-Myers Squibb Co (BMY) as of May 13, 2011, with a value of $10 Million and a weighting of 81.84%. Anthony C Hooper also owns 338,394 shares of MannKind Corp (MNKD) as of February 28, 2022, with a value of $2 Million and a weighting of 18.16%.
Latest Holdings of Anthony C Hooper
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2011-05-13 | 208,419 | 49.02 | 10,216,699 |
| MNKD | MannKind Corp | 2022-02-28 | 338,394 | 6.70 | 2,267,240 |
Holding Weightings of Anthony C Hooper
Anthony C Hooper Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony C Hooper has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 13,372 shares on May 13, 2011, which brought Anthony C Hooper around $385,114.
According to the SEC Form 4 filings, Anthony C Hooper has made a total of 1 transactions in MannKind Corp (MNKD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in MannKind Corp is the acquisition of 40,000 shares on February 28, 2022, which cost Anthony C Hooper around $108,400.
Insider Trading History of Anthony C Hooper
- 1
Anthony C Hooper Trading Performance
GuruFocus tracks the stock performance after each of Anthony C Hooper's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony C Hooper is 69.47%. GuruFocus also compares Anthony C Hooper's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony C Hooper within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anthony C Hooper's insider trading performs compared to the benchmark.
Performance of Anthony C Hooper
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 37.02 | | | | | |
| Relative Return to S&P 500(%) | 32.41 | | | | | |
Anthony C Hooper Ownership Network
Anthony C Hooper Owned Company Details
What does BeiGene Ltd do?
Who are the key executives at BeiGene Ltd?
Anthony C Hooper is the director of BeiGene Ltd. Other key executives at BeiGene Ltd include President and GM China Xiaobin Wu , SVP & General Counsel Chan Henry Lee , and Chief Financial Officer Julia Aijun Wang .
BeiGene Ltd (BGNE) Insider Trades Summary
Over the past 18 months, Anthony C Hooper made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 28,808 shares made by Xiaobin Wu , a net sale of 4,186 shares made by Julia Aijun Wang , and a net sale of 6,300 shares made by Lai Wang .
In summary, during the past 3 months, insiders sold 18,210 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 18,210 shares. During the past 18 months, 5,400,960 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,400,960 shares.
BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
BeiGene Ltd Insider Transactions
Anthony C Hooper Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony C Hooper. You might contact Anthony C Hooper via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
